SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
沐浠
Lv4
2
440 积分
2024-01-31 加入
最近求助
最近应助
互助留言
decision tree-Markov model of Perinatal depression screening: a cost-utility analysis
7天前
已完结
Cost-effectiveness of treating relapsed or refractory 3L+ follicular lymphoma with axicabtagene ciloleucel vs mosunetuzumab in the United States
7天前
已完结
Extrapolation of Survival Curves Using Standard Parametric Models and Flexible Parametric Spline Models: Comparisons in Large Registry Cohorts with Advanced Cancer
10天前
已完结
The Cost-Effectiveness of Pertuzumab for the Treatment of Metastatic HER2+ Breast Cancer in Czechia: A Semi-Markov Model Using Cost States
1个月前
已完结
Economic Evaluation for the UK of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer
2个月前
已完结
FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer
2个月前
已完结
Patients value metastatic cancer therapy more highly than is typically shown through traditional estimates
3个月前
已关闭
Economic evaluations of first-line chemotherapy regimens for pancreatic cancer: a critical review
3个月前
已完结
Economic Evaluation for USA of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer
3个月前
已完结
S-1 or gemcitabine adjuvant therapy in resected pancreatic cancer: a cost-effectiveness analysis based on the JASPAC-01 trial
3个月前
已完结
没有进行任何应助
感谢
1个月前
感谢
2个月前
感谢
2个月前
感谢
3个月前
感谢
3个月前
更改不了题目【积分已退回】
3个月前
标题错误。正确的题目应为 S-1 or gemcitabine adjuvant therapy in resected pancreatic cancer: a cost-effectiveness analysis based on the JASPAC-01 trial. Expert Rev Pharmacoecon Outcomes Res. 于2020年发表。
3个月前
感谢
3个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论